{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T17:55:08Z","timestamp":1781546108472,"version":"3.54.5"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"UKE Foundation"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Liposarcomas (LS) of the extremities and trunk are aggressive soft-tissue sarcomas and surgical resection combined with multimodal therapy represents the cornerstone of curative treatment. Despite advances in surgical and medical management patients are still at risk of developing medical complications that negatively affect morbidity and mortality. Kidney dysfunction, sarcopenia and progressive loss of visceral adipose tissue have emerged as prognostically relevant and potentially treatable complications in surgical oncology. However, despite their growing relevance, little is known about their frequency and impact on survival and morbidity in the context of LS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective study of 47 adult patients with localized LS of the extremities and trunk who underwent curative-intent surgery. Kidney function, CT morphometry of muscle (skeletal muscle index, SMI) and visceral adipose tissue (VAT) as well as clinical assessments including ECOG score were recorded at diagnosis (t1) and after a median follow-up (t2) of 11 months. Kidney dysfunction, defined as a decrease in eGFR of \u2265 25% between time points, was analyzed in relation to survival, sequentially assessed CT-morphometry of muscle and adipose tissue as well as functional status assessed by ECOG scores.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>All patients underwent curative-intent surgical treatment with or without additional multimodal treatment (surgery only: 51.1%, additional radiation: 31.9%, additional chemotherapy: 38.3%). Kidney dysfunction was frequent in our cohort (53.2% of all patients) and significantly associated reduced overall survival in Kaplan\u2013Meier, uni- and multivariate Cox proportional hazards regression models (multivariate hazard ratio: 6.7; p\u2009=\u20090.03). In addition, patients with kidney dysfunction experienced a significantly accelerated loss of SMI (p\u2009&lt;\u20090.001) and VAT (p\u2009&lt;\u20090.001) as well as accelerated functional deterioration measured by worsening ECOG scores between t1 and t2 compared to a stable ECOG score in patients without kidney dysfunction (odds ratio of ECOG increase of: 8.0; p\u2009=\u20090.0027).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>To our knowledge, this is among the first studies to investigate kidney dysfunction and its consequences in adult LS patients. In our cohort of surgically treated adult patients with LS of the extremities and trunk, kidney dysfunction was a frequent and clinically impactful complication. It was significantly associated with decreased overall survival, loss of muscle and adipose tissue in sequential CT morphometry assessments and progressive functional decline. Off note, CT-morphometry enabled objective, high-resolution tracking of body composition decline and may serve as a promising additional tool for risk stratification. Nonetheless, given the limited cohort size and retrospective single-center design, the generalizability of our findings is limited and the results should therefore be interpreted with caution. Despite these limitations, our findings call for future prospective studies and an awareness for heightened renal surveillance and integrated body composition assessments in the multimodal management of sarcoma patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0351181","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T17:23:37Z","timestamp":1781544217000},"page":"e0351181","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Kidney dysfunction is associated with mortality, adverse CT-based muscle metrics, and functional decline in surgically treated liposarcomas of the extremities and trunk"],"prefix":"10.1371","volume":"21","author":[{"given":"Julian","family":"Kylies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5440-1035","authenticated-orcid":true,"given":"Fabian","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dupr\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias B.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Heinz","family":"Frosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Priemel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8801-0354","authenticated-orcid":true,"given":"Dominik","family":"Kylies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"issue":"25","key":"pone.0351181.ref001","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.18632\/oncotarget.26809","article-title":"Sarcomas in the United States: recent trends and a call for improved staging","volume":"10","author":"MM Gage","year":"2019","journal-title":"Oncotarget"},{"key":"pone.0351181.ref002","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1200\/EDBK_200589","article-title":"Global health perspective in sarcomas and other rare cancers","volume":"38","author":"V Florou","year":"2018","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"22","key":"pone.0351181.ref003","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.3390\/cancers16223858","article-title":"Liposarcoma: a journey into a rare tumor\u2019s epidemiology, diagnosis, pathophysiology, and limitations of current therapies","volume":"16","author":"E Jonczak","year":"2024","journal-title":"Cancers (Basel)"},{"key":"pone.0351181.ref004","article-title":"Liposarcoma.","volume-title":"StatPearls","author":"R Zafar","year":"2025"},{"issue":"2","key":"pone.0351181.ref005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246958","article-title":"Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network","volume":"16","author":"G de Pinieux","year":"2021","journal-title":"PLoS One"},{"key":"pone.0351181.ref006","first-page":"506182","article-title":"Guidelines for the management of soft tissue sarcomas","volume":"2010","author":"R Grimer","year":"2010","journal-title":"Sarcoma"},{"key":"pone.0351181.ref007","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.12688\/f1000research.10050.1","article-title":"Recent advances in the management of liposarcoma","volume":"5","author":"NA Nassif","year":"2016","journal-title":"F1000Res"},{"issue":"1","key":"pone.0351181.ref008","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41416-024-02674-y","article-title":"UK guidelines for the management of soft tissue sarcomas","volume":"132","author":"AJ Hayes","year":"2025","journal-title":"Br J Cancer"},{"key":"pone.0351181.ref009","article-title":"Epidemiology and survival of liposarcoma and its subtypes: A dual database analysis","volume":"11","author":"KM Amer","year":"2020","journal-title":"J Clin Orthop Trauma"},{"key":"pone.0351181.ref010","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.3390\/ijerph17082710","article-title":"Increasing incidence of liposarcoma: a population-based study of national surveillance databases, 2001-2016","volume":"17","author":"S Bock","year":"2020","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"pone.0351181.ref011","doi-asserted-by":"crossref","DOI":"10.1053\/j.ackd.2022.04.001","article-title":"Oncosurgery-related acute kidney injury","volume":"29","author":"W Zafar","year":"2022","journal-title":"Adv Chronic Kidney Dis"},{"issue":"5","key":"pone.0351181.ref012","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/ckj\/sfab292","article-title":"Treatment of acute kidney injury in cancer patients","volume":"15","author":"P Braet","year":"2021","journal-title":"Clin Kidney J"},{"issue":"1","key":"pone.0351181.ref013","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12029-025-01169-0","article-title":"Prevalence and risk factors of acute kidney injury after colorectal cancer surgery","volume":"56","author":"AE Abdulgalil","year":"2025","journal-title":"J Gastrointest Cancer"},{"issue":"1","key":"pone.0351181.ref014","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1159\/000540908","article-title":"Acute kidney disease in oncology: a new concept to enhance the understanding of the impact of kidney injury in patients with cancer","volume":"49","author":"M Floris","year":"2024","journal-title":"Kidney Blood Press Res"},{"issue":"3","key":"pone.0351181.ref015","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70646","article-title":"Risk of and mortality after acute kidney injury following cancer treatment: a cohort study","volume":"14","author":"PV Munch","year":"2025","journal-title":"Cancer Med"},{"issue":"1","key":"pone.0351181.ref016","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1186\/s12885-023-11329-9","article-title":"The risk of acute kidney injury in colorectal cancer survivors: an english population-based matched cohort study","volume":"23","author":"K Andresen","year":"2023","journal-title":"BMC Cancer"},{"issue":"6","key":"pone.0351181.ref017","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/ajh.25764","article-title":"Treatment and disease-related complications in multiple myeloma: Implications for survivorship","volume":"95","author":"R Chakraborty","year":"2020","journal-title":"Am J Hematol"},{"issue":"9","key":"pone.0351181.ref018","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.3390\/ijms22094618","article-title":"Nephrotoxicity as a complication of chemotherapy and immunotherapy in the treatment of colorectal cancer, melanoma and non-small cell lung cancer","volume":"22","author":"J Jagie\u0142a","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"8","key":"pone.0351181.ref019","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1007\/s00432-022-04437-9","article-title":"Acute kidney injury in advanced lung cancer patients treated with PD-1 inhibitors: a single center observational study","volume":"149","author":"K Liu","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"pone.0351181.ref020","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.565023","article-title":"Mitochondrial dysfunction in kidney disease and uremic sarcopenia","volume":"11","author":"K Takemura","year":"2020","journal-title":"Front Physiol"},{"key":"pone.0351181.ref021","doi-asserted-by":"crossref","first-page":"115407","DOI":"10.1016\/j.bcp.2022.115407","article-title":"Chronic kidney disease-induced muscle atrophy: Molecular mechanisms and promising therapies","volume":"208","author":"K Wang","year":"2023","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"pone.0351181.ref022","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/jso.24025","article-title":"The impact of sarcopenia on survival and complications in surgical oncology: a review of the current literature","volume":"112","author":"S Joglekar","year":"2015","journal-title":"J Surg Oncol"},{"key":"pone.0351181.ref023","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.tipsro.2020.10.001","article-title":"Sarcopenia in cancer: risking more than muscle loss","volume":"16","author":"M Anjanappa","year":"2020","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"issue":"3","key":"pone.0351181.ref024","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3390\/nu13030761","article-title":"Sarcopenia, malnutrition, and cachexia: adapting definitions and terminology of nutritional disorders in older people with cancer","volume":"13","author":"D Meza-Valderrama","year":"2021","journal-title":"Nutrients"},{"issue":"6","key":"pone.0351181.ref025","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.3390\/nu13061980","article-title":"The spectrum of malnutrition\/cachexia\/sarcopenia in oncology according to different cancer types and settings: a narrative review","volume":"13","author":"P Bossi","year":"2021","journal-title":"Nutrients"},{"issue":"19","key":"pone.0351181.ref026","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1200\/JCO.21.00102","article-title":"Sarcopenia in the older adult with cancer","volume":"39","author":"GR Williams","year":"2021","journal-title":"J Clin Oncol"},{"issue":"3","key":"pone.0351181.ref027","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/jcsm.12073","article-title":"Sarcopenia and mortality among a population-based sample of community-dwelling older adults","volume":"7","author":"JC Brown","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"6","key":"pone.0351181.ref028","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/sj.ijo.0800875","article-title":"Weight loss increases and fat loss decreases all-cause mortality rate: results from two independent cohort studies","volume":"23","author":"DB Allison","year":"1999","journal-title":"Int J Obes Relat Metab Disord"},{"key":"pone.0351181.ref029","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.avsg.2017.08.002","article-title":"Morphometric assessment as a predictor of outcome in older vascular surgery patients","volume":"47","author":"MM Chowdhury","year":"2018","journal-title":"Ann Vasc Surg"},{"issue":"9","key":"pone.0351181.ref030","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1007\/s00261-021-03294-3","article-title":"Sarcopenia: imaging assessment and clinical application","volume":"47","author":"V Chianca","year":"2022","journal-title":"Abdom Radiol (NY)"},{"issue":"7","key":"pone.0351181.ref031","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00256-021-03951-0","article-title":"Computed tomography-based body composition profile as a screening tool for geriatric frailty detection","volume":"51","author":"O Laur","year":"2022","journal-title":"Skeletal Radiol"},{"issue":"6","key":"pone.0351181.ref032","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/ajcn\/nqac273","article-title":"Association of visceral adipose tissue with postoperative outcome in upper gastrointestinal cancer: a systematic review and meta-analysis","volume":"116","author":"R Matsui","year":"2022","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"pone.0351181.ref033","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/jcsm.13425","article-title":"Prevalence of sarcopenia in patients with chronic kidney disease: a global systematic review and meta-analysis","volume":"15","author":"MP Duarte","year":"2024","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"5","key":"pone.0351181.ref034","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3390\/medicina60050745","article-title":"Sarcopenia, a risk predictor of postoperative acute kidney injury in elderly patients after hip fracture surgery: a retrospective analysis","volume":"60","author":"SY Koh","year":"2024","journal-title":"Medicina (Kaunas)"},{"issue":"11","key":"pone.0351181.ref035","doi-asserted-by":"crossref","DOI":"10.1172\/JCI135821","article-title":"Pro-cachectic factors link experimental and human chronic kidney disease to skeletal muscle wasting programs","volume":"131","author":"F Solagna","year":"2021","journal-title":"J Clin Invest"},{"issue":"3","key":"pone.0351181.ref036","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/jcsm.12705","article-title":"Association of sarcopenia with mortality and end-stage renal disease in those with chronic kidney disease: a UK Biobank study","volume":"12","author":"TJ Wilkinson","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"7","key":"pone.0351181.ref037","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.3390\/nu13072212","article-title":"Impact of sarcopenia on acute kidney injury after infrarenal abdominal aortic aneurysm surgery: a propensity matching analysis","volume":"13","author":"J-Y Bang","year":"2021","journal-title":"Nutrients"},{"key":"pone.0351181.ref038","doi-asserted-by":"crossref","first-page":"1059668","DOI":"10.3389\/fneph.2023.1059668","article-title":"Impact of cardiac surgery associated acute kidney injury on 1-year major adverse kidney events","volume":"3","author":"A Molina And\u00fajar","year":"2023","journal-title":"Front Nephrol"},{"issue":"1","key":"pone.0351181.ref039","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13613-024-01281-7","article-title":"Influence of fluid accumulation on major adverse kidney events in critically ill patients - an observational cohort study","volume":"14","author":"DM Hofer","year":"2024","journal-title":"Ann Intensive Care"},{"issue":"1","key":"pone.0351181.ref040","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/PAP.0000000000000284","article-title":"The 2020 WHO classification of tumors of soft tissue: selected changes and new entities","volume":"28","author":"JH Choi","year":"2021","journal-title":"Adv Anat Pathol"},{"issue":"4","key":"pone.0351181.ref041","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1007\/s00330-019-06573-2","article-title":"Imaging of sarcopenia: old evidence and new insights","volume":"30","author":"D Albano","year":"2020","journal-title":"Eur Radiol"},{"issue":"3","key":"pone.0351181.ref042","first-page":"200","article-title":"Soft-tissue sarcoma in adults: an update on the current state of histiotype-specific management in an era of personalized medicine","volume":"70","author":"AC Gamboa","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"pone.0351181.ref043","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13045-024-01580-3","article-title":"New strategies in soft tissue sarcoma treatment","volume":"17","author":"M Spalato-Ceruso","year":"2024","journal-title":"J Hematol Oncol"},{"key":"pone.0351181.ref044","doi-asserted-by":"crossref","first-page":"109340","DOI":"10.1016\/j.ejrad.2020.109340","article-title":"Impact of CT-based body composition parameters at baseline, their early changes and response in metastatic cancer patients treated with immune checkpoint inhibitors","volume":"133","author":"A Cromb\u00e9","year":"2020","journal-title":"Eur J Radiol"},{"issue":"4","key":"pone.0351181.ref045","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2214\/AJR.22.27749","article-title":"CT-derived body composition assessment as a prognostic tool in oncologic patients: from opportunistic research to artificial intelligence-based clinical implementation","volume":"219","author":"DDB Bates","year":"2022","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"pone.0351181.ref046","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1186\/s12957-022-02846-1","article-title":"Sarcopenia is associated with worse surgical complications but not relapse-free survival and overall survival in patients with retroperitoneal liposarcoma","volume":"20","author":"M Zhao","year":"2022","journal-title":"World J Surg Oncol"},{"issue":"5","key":"pone.0351181.ref047","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1053\/j.seminoncol.2008.07.004","article-title":"The role of the Eastern Cooperative Oncology Group in establishing standards of cancer care: over 50 years of progress through clinical research","volume":"35","author":"Eastern Cooperative Oncology Group","year":"2008","journal-title":"Semin Oncol"},{"issue":"2","key":"pone.0351181.ref048","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1681\/ASN.2015030261","article-title":"Inflammation in AKI: current understanding, key questions, and knowledge gaps","volume":"27","author":"H Rabb","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"pone.0351181.ref049","unstructured":"Evidence-based Guidelines: Soft Tissue Sarcoma Version 1.1 - AWMF-Guideline 032\/044OL; 2022."},{"issue":"11","key":"pone.0351181.ref050","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.annonc.2021.07.006","article-title":"Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2606","volume":"32","author":"A Gronchi","year":"2021","journal-title":"Ann Oncol"},{"issue":"3","key":"pone.0351181.ref051","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3390\/diagnostics13030402","article-title":"Changes in CT-based morphological features of the kidney with declining glomerular filtration rate in chronic kidney disease","volume":"13","author":"YH Choi","year":"2023","journal-title":"Diagnostics (Basel)"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0351181","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T17:23:46Z","timestamp":1781544226000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0351181"}},"subtitle":[],"editor":[{"given":"Robert Jeenchen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":51,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0351181","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]}}}